Peptide Comparison
5-Amino-1MQvsSemaglutide
A small-molecule NNMT inhibitor studied in animals for fat loss and NAD+ metabolism.
The revolutionary once-weekly GLP-1 medication that helps your body feel full faster and longer, leading to significant weight loss while also protecting your heart—FDA approved and backed by some of the largest clinical trials in obesity medicine history.
At a Glance
Quick
comparison
Dose Range
5-Amino-1MQ
50–150 mg
Semaglutide
0.25–2.4 mg
Frequency
5-Amino-1MQ
Once daily
Semaglutide
Once weekly
Administration
5-Amino-1MQ
Subcutaneous injection
Semaglutide
Subcutaneous injection
Cycle Length
5-Amino-1MQ
8-12 weeks (community-reported; no human trial data)
Semaglutide
Ongoing/indefinite
Onset Speed
5-Amino-1MQ
Not established in humans; gradual over weeks in animal studies
Semaglutide
Moderate (1-2 weeks)
Evidence Level
5-Amino-1MQ
Preclinical only (animal and lab studies; no human trials)
Semaglutide
Strong human trials (Phase 3 or FDA approved)
Efficacy
Benefit
ratings
Fat and weight reduction
Metabolic markers
NAD+ / cellular energy
Human evidence
Weight Loss
Appetite Control
Heart Protection
Technical Data
Compound
specifications
5-Amino-1MQ
Molecular Formula
C10H11N2+ (cation); commonly supplied as the iodide salt (C10H11IN2)
Molecular Weight
159.21 g/mol (cation); 286.11 g/mol (iodide salt)
Half-Life
Not established in humans; preclinical rodent data suggest a few hours (compound is membrane-permeable and orally active)
Bioavailability
Orally bioavailable in animal studies (high membrane permeability shown by PAMPA and Caco-2 assays); human data not established
CAS Number
42464-96-0 (salt form)
Semaglutide
Molecular Formula
C187H291N45O59
Molecular Weight
4113.58 g/mol
Half-Life
Approximately 7 days (168 hours)
Bioavailability
89% (subcutaneous); 0.4-1% (oral, with absorption enhancer)
CAS Number
910463-68-2
Protocols
Dosing
tiers
5-Amino-1MQ
Semaglutide
Applications
Best
suited for
5-Amino-1MQ
Fat loss research
The clearest, most repeated finding: obese mice lost body weight and fat mass on 5-Amino-1MQ without eating less [1][2]. This is the main reason people are interested — though it is animal data, not human proof.
Metabolic health support
In mice, it improved blood sugar, insulin, and liver fat [2]. Researchers see NNMT inhibition as a promising angle for metabolic syndrome [4].
NAD+ and cellular energy science
By blocking NNMT, it raises NAD+ and SAM inside cells, which supports how cells make and use energy [1][4]. This makes it interesting to people studying aging and metabolism.
Semaglutide
People with Obesity Seeking Significant Weight Loss
If your BMI is 30 or higher (or 27+ with weight-related health conditions), semaglutide is currently one of the most effective non-surgical weight loss options available. Clinical trials show average weight loss of 15% of body weight—that's 30+ pounds for someone starting at 200 pounds.
Those Who've Struggled with Diet and Exercise Alone
Semaglutide works by changing the biological signals that drive hunger and cravings. If you've tried to lose weight through willpower alone and found yourself constantly battling hunger, this medication addresses that underlying biology rather than just telling you to eat less.
People with Type 2 Diabetes Needing Better Control
Originally developed for diabetes, semaglutide excellently controls blood sugar while also promoting weight loss—addressing two major health concerns simultaneously. It can often allow people to reduce or eliminate other diabetes medications.
Individuals at High Cardiovascular Risk
The SELECT trial proved that semaglutide reduces heart attacks, strokes, and cardiovascular death by 20% in people with obesity and existing heart disease—even without diabetes. It's one of the few weight loss medications proven to improve hard cardiovascular outcomes.
Safety Profile
Side
effects
5-Amino-1MQ
Common
- No verified human side effects
- Mild nausea or headache (community-reported)
Uncommon
- Fatigue or flushing (community-reported)
Serious
- Possible off-target MAO-A effects (theoretical)
- Unknown long-term and human risks
Semaglutide
Common
- Nausea
- Constipation or Diarrhea
- Decreased Appetite
- Vomiting
Uncommon
- Gallbladder Problems
- Hair Loss (Telogen Effluvium)
Serious
- Pancreatitis
- Thyroid Tumors (Theoretical Risk)
Research Status
Safety
& evidence
5-Amino-1MQ
Evidence Level
Preclinical only (animal and lab studies; no human trials)
FDA Status
Research compound — not FDA approved
Safety Overview
Here is the honest picture: no one has run a human safety trial on 5-Amino-1MQ. Everything we know about safety comes from mice. In those studies, the animals tolerated it well — no obvious harm, no change in appetite, and healthier livers at the doses tested [1][2]. But mice are not people, and short animal studies cannot rule out problems that show up over months or years in humans. Treat this as an experimental compound. If you are considering it, talk to a doctor first, especially if you take any medication.
Contraindications
- xNo human safety data exists — all evidence is from animals and lab work
- xPregnancy or breastfeeding
- xUse with MAO-A-sensitive medications, given off-target MAO-A inhibition seen in lab screening [2]
Semaglutide
Evidence Level
Strong human trials (Phase 3 or FDA approved)
FDA Status
FDA approved for this use
Safety Overview
Semaglutide has been studied in over 20,000 participants across multiple large clinical trials, making it one of the most thoroughly researched weight loss medications available. The FDA approved it after rigorous review of safety data. While GI side effects are common (especially early on), serious side effects are rare. The SELECT trial showed it actually reduces cardiovascular events, adding a safety benefit beyond just weight loss.
Contraindications
- xPersonal or family history of medullary thyroid carcinoma (MTC)
- xMultiple Endocrine Neoplasia syndrome type 2 (MEN2)
- xHistory of serious allergic reaction to semaglutide
- xCurrent or recent pancreatitis
- xPregnancy or planning to become pregnant
Decision Guide
Which is
right for you?
Choose 5-Amino-1MQ if...
- Fat loss (research context)
- Metabolic health support
- NAD+ and cellular energy metabolism
Choose Semaglutide if...
- Significant weight loss
- Long-term weight management
- Cardiovascular risk reduction
- Blood sugar control